In accordance with our hypothesis, members of the NF-κB family have been reported to promote urinary cancer of the bladder via increasing angiogenesis, resistance against cisplatin and enhanced epithelial mesenchymal transition [18, 47, 48]. This evidence concerns the gene NFKB1 and urinary bladder cancer.